Chemical formula: C₂₆H₂₇N₅O₂ Molecular mass: 441.525 g/mol PubChem compound: 6918314
Vilazodone is a selective serotonin reuptake inhibitor and a 5HT1A receptor partial agonist. It is used for the treatment of major depressive disorder (MDD) in adults. The mechanism of action of vilazodone in the treatment of major depressive disorder is not fully understood, but is thought to be related to its enhancement of serotonergic activity in the CNS through selective inhibition of serotonin reuptake.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N06AX24 | Vilazodone | N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AX Other antidepressants |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| VIIBRYD Tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
Vilazodone is an active ingredient of these brands:
United States (US)
Brazil (BR)
Canada (CA)
Ecuador (EC)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
